Home » Market News » DirectorsTalk Highlights » Sativa to Shift From Canadian Investments to U.K. Trading
Sativa Investments plc

Sativa to Shift From Canadian Investments to U.K. Trading

Sativa Investments PLC was established as a medical cannabis investment vehicle in March last year with the aim of investing primarily in Canadian companies. However, following the faster-than-expected legalization of medicinal cannabis in the U.K. last November, Sativa has changed its strategy to focus on British operations.

This shift to trading means it will change its name to Sativa Group, it said in a statement to the London NEX Exchange. It believes that and other moves will ‘broaden the appeal of the equity opportunity to additional institutions and family offices, many of which are precluded from investing in fund-type vehicles’.

Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.